Effect of soybean administration on the pharmacokinetics of carbamazepine and omeprazole in rats

Fundamental and Clinical Pharmacology

Volumn 24, Issue 3, 2010, Pages 351-355

  Singh, Dharmender ^a   Asad, Mohammed ^a  

^a KRUPANIDHI COLLEGE OF PHARMACY   (India)

Author keywords

Carbamazepine; Interaction; Omeprazole; Pharmacokinetic; Soybean

Indexed keywords

CARBAMAZEPINE; OMEPRAZOLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG INHIBITION; DRUG POTENTIATION; DRUG SELECTIVITY; FEMALE; FOOD DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SOYBEAN; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CARBAMAZEPINE; FEMALE; FOOD-DRUG INTERACTIONS; MALE; OMEPRAZOLE; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS; SOYBEANS;

EID: 77952575634     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00762.x     Document Type: Article

References (23)

1. Evans W.C. Trease and Evans Pharmacognosy, 14th edn, WB Saunders
2. Cambria-Kiely J.A. Effect of soy milk on warfarin efficacy. Ann. Pharmcother. (2002) 36 1893 1896.
3. Rivas M., Garay R.P., Escanero J.F., Cia P. Jr., Cia P., Alda J.O. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J. Nutr. (2002) 132 1900 1902. (Pubitemid 34742874)
4. Ho S.C., Woo J.L., Leung S.S., Sham A.L., Lam T.H., Janus E.D. Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J. Nutr. (2000) 130 2590 2593.
5. Ravindranath M.H., Muthugounder S., Presser N., Viswanathan S. Laboratory of Glycoimmunotherapy Santa Monica. Adv. Exp. Med. Biol. (2004) 546 121 165.
6. Cassidy A., Hooper L. Phytoestrogens and cardiovascular disease. J. Br. Menopause Soc. (2006) 12 49 56. (Pubitemid 43881063)
7. Clair R.S., Anthony M. Soy, isoflavones and atherosclerosis. Handb. Exp. Pharmacol. (2005) 170 301 323.
8. Kishida T., Nagamoto M., Ohtsu Y., et al. Lack of an inducible effect of dietary soy isoflavones on the mRNA abundance of hepatic cytochrome P-450-isozymes in rats. Biosci. Biotechnol. Biochem. (2004) 68 508 515. (Pubitemid 39251485)
9. Foster B.C., Vandenhoek S., Hana J., et al. In vitro inhibition of human cytochrome P-450-mediated metabolism of marker substrates by natural products. Phytomedicine (2003) 10 334 342. (Pubitemid 36597170)
10. Anderson G.D., Rosito G., Mohustsy M.A., Elmer G.W. Drug interaction potential of soy extract and Panax ginseng. J. Clin. Pharmacol. (2003) 43 643 648. (Pubitemid 36613123)
11. Wilkinson G.R. Pharmacokinetics: the dynamics of drug absorption, distribution and elimination, in : Hardman J.G., Limbird L.E. (Eds Goodman and Gilman's the pharmacological basis of therapeutics, 10th edn, McGraw Hill
12. Kang P., Liao M., Wester M.R., Leeder J.S., Pearce R.E., Correia M.A. CYP3A4-mediated carbamazepine (cbz) metabolism: formation of a covalent cbz-cyp3a4 adduct and alteration of the enzyme kinetic profile. Drug Metab. Dispos. (2008) 36 490 499. (Pubitemid 351409335)
13. Yin O.Q., Tomlinson B., Chow A.H., Waye M.M., Chow M.S. Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability. Clin. Pharmacol. (2004) 44 582 589. (Pubitemid 38668020)
14. Hermida J., Boveda M.D., Vadillo F.J., Tutor J.C. Comparison between the Cobas Integra immunoassay and high-performance liquid chromatography for therapeutic monitoring of carbamazepine. Clin. Biochem. (2002) 35 251 254. (Pubitemid 34638853)
15. Vogel G.H. Drug discovery and evaluation, 2nd edn, Springer-Verlag Berlin Heidelberg
16. Gerson B. Antiepileptic agents by reversed phase liquid chromatography. Clin. Chem. (1984) 30 105 108.
17. Watanabe K., Furuno K., Eto K., Oishi R., Gomita Y. First-pass metabolism of omeprazole in rats. J. Pharm. Sci. (1994) 83 1131 1134. (Pubitemid 24247350)
18. Yuen K.H. Improved high performance liquid chromatographic analysis of omeprazole. J. Pharm. Biomed. Anal. (2001) 24 715 719. (Pubitemid 32119589)
19. Nishimukai M., Hara H., Aoyama Y. The addition of soybean phosphatidylcholine to triglyceride increases suppressive effects on food intake and gastric emptying in rats. J. Nutr. (2003) 133 1255 1258. (Pubitemid 36548691)
20. Shannon H.E., Love P.L. Effects of antiepileptic drugs on attention as assessed by a five-choice serial reaction time task in rats. Epilep. Behav. (2005) 7 620 628.
21. Takahata T., Yasui-Furukori N., Yoshiya G., Uno T., Sugawara K., Tateishi T. Fexofenadine does not affect omeprazole pharmacokinetics: both are putative P-glycoprotein substrates. Basic Clin. Pharmacol. Toxicol. (2004) 94 252 256. (Pubitemid 38667872)
22. Owen A., Pirmohamed M., Tettey J.N., Morgan P., Chadwick D., Park B.K. Carbamazepine is not a substrate for P-glycoprotein. Pharmacology (2001) 51 345 349. (Pubitemid 32391490)
23. Castro A.F., Altenberg G. AInhibition of drug transport by Genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem. Pharmacol. (1997) 53 89 93. (Pubitemid 26419790)